Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Duloxetine As an Analgesic in Patients Without Central Sensitivity Undergoing Single-sitting, Bilateral Total Knee Arthroplasty: a Prospective, Double-blinded, Randomised, Placebo-controlled Trial

NCT06837012 is registered in ClinicalTrials.gov with Orthopaedic Arthroscopy Knee and Shoulder Clinic as lead sponsor.

NCT NCT06837012
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06837012 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Duloxetine As an Analgesic in Patients Without Central Sensitivity Undergoing Single-sitting, Bilateral Total Knee Arthroplasty: a Prospective, Double-blinded, Randomised, Placebo-controlled Trial
Lead sponsor
Orthopaedic Arthroscopy Knee and Shoulder Clinic
Phase
Phase 4
Overall status
Completed
Start date
January 1, 2021
Completion date
July 31, 2022
Enrollment
106 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

central sensitisation, central sensitization, osteoarthritis of knee